Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-22
1997-07-01
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 54, 514909, A61K 3800
Patent
active
056438745
ABSTRACT:
A pharmaceutical composition containing a glucosidase and/or amylase inhibitor and a lipase inhibitor as active substances and usual pharmaceutical carriers.
REFERENCES:
patent: 4189438 (1980-02-01), Umezawa et al.
patent: 4254256 (1981-03-01), Otani et al.
patent: 4273765 (1981-06-01), Suhara et al.
patent: 4358602 (1982-11-01), Umezawa et al.
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4623714 (1986-11-01), Vertesey et al.
patent: 4952567 (1990-08-01), DeMeyts et al.
patent: 5036081 (1991-07-01), Matsuo et al.
patent: 5240962 (1993-08-01), Naktsu et al.
Lehninger, Biochemistry, Second Edition, Worth Publishers, Inc., New York: 1975, p. 265.
Antidiabetic Agents, 30th Edition, Martindale Extra Pharmacopoeia, 276, no date available.
Hauptman et al., Initial Studies in Humans with the Novel Gastrointestinal Lipase Inhibitor Ro 18-0646 (tetrahydro-lipstatin).sup.1,2, Am. J. Nutr. 1992:55:309S-313S.
M. Negwer, Organic-Chemical Drugs and Their Synonyms, 6. Auflage, vol. II 1987, pp. 1310; 1311; 1547; 1652.
B.W. Bycroft, Dictionary of Antibiotics and Related Substances, 1988, Champman and Hall, London, New York, pp. 15; 298; 315; 445; 698.
Annual Drug Data Report (Published by Prous, Barcelona, Spain) (1992) 14(1), 46.
Annual Drug Data Report (Published by Prous, Barcelona, Spain) (1987) 9(7), 603.
Annual Drug Data Report (Published by Prous, Barcelona, Spain) (1986) 8(3), 276.
Annual Drug Data Report (Published by Prous, Barcelona, Spain) (1986) 8(?), 558.
Annual Drug Data Report (Published by Prous, Barcelona, Spain) (1990) 12(8), 636.
Annual Drug Data Report (Published by Prous, Barcelona, Spain) (1992) 14(7) 610.
Annual Drug Data Report (Published by Prous, Barcelona, Spain) (1992) 14(7), 606.
Federation Proceedings (1982) 41(3), 698.
WHO Chronicle (1980) 34 (Suppl.).
Int. J. Obesity, 1992; 16 (Suppl. 1):16, Abstr. 063.
Merck Index, 11th Ed. 1989 p. 4.
Annual Drug Data Report Dept. 1991, pp. 590-591.
Annual Drug Data Report p. 723 (1992).
Annual Drug Data Report p. 167 (1985).
Annual Drug Report p. 343 (1987).
J. Antibiotics XXXI No. 8, Kondo, et al., 1978.
J. of Antibiotics vol. 35, No. 9 (1982) pp. 1160-1166.
J. Antibiot. XL (1987) pp. 1647-1650.
Bremer Klaus-Dieter
Sawlewicz Pavel
Ciambrone Coletti Ellen
Hoffmann-La Roche Inc.
Johnston George W.
Kunz Gary L.
LandOfFree
Pharmaceutical composition comprising a glucosidase and/or amyla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising a glucosidase and/or amyla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising a glucosidase and/or amyla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597099